Lumida
/VLN
⌘K
VLN

VLN

VLN
$1.71USD-1.16%-0.02 today

MARKET CAP

185.1M

P/E (TTM)

FWD P/E

DAY RANGE

$2 – $2

52W RANGE

$1
$4

The case for & against

Bull & Bear analysis

Bearish

Valens Semiconductor (NYSE: VLN) operates within the semiconductor industry, specializing in advanced HDBaseT chipsets for various applications including audio-visual, home entertainment, and enterprise solutions. The company is positioned as an emerging player in the high-growth market of connectivity solutions, particularly in the growing demand for high-definition video and data transmission across various sectors. Valens is strategically aligned with trends focused on seamless connectivity and digital transformation in both consumer and B2B sectors.

Bull says

  • HDBaseT chipset sales in Barco ClickShare kit support uncompressed 4K video.
  • Order backlog growth driven by nuclear and oil sector bookings suggests robust demand.
  • Analysts project 17% CAGR in revenue over next three years.
  • Dividend yield near 1.29% shows shareholder return commitment amid volatility.
  • Liquidity ratio at 1.31 supports operations and potential buybacks/dividends.
  • Strong innovation focus and new partnerships may boost market share.

Bear says

  • Earnings yield negative at -1.84% indicates poor profitability.
  • Sales dropped 14% over three years with recent EPS cuts.
  • Stock price at $2.07, down 7.2% yesterday and 8.8% in 10 days.
  • High short interest and volatility undermine investor confidence.
  • Debt leverage remains concerning despite 18% QoQ debt reduction.
  • Leadership change with new CFO may disrupt strategy execution.

Earnings Call · Q3 2024 · Mgmt. Guidance

Updated 06-04-2026neutral

Transcript signals

Bull points

  • Sales from continuing operations grew more than 18% as we executed on our solid and diversified backlog. We also delivered a significant improvement of profitability, with adjusted net income from continuing operations of $8.5 million, driven by a favorable mix, efficiency gains, and better absorption, compared to a $7 million loss a year ago.
  • the measures implemented to improve cash flow generation, including leveraging the global scale of our business, maximizing strategic procurement, and optimizing our inventory are paying off. Cash flow will enable us to invest in key growth opportunities for the business going forward.
  • Our order backlog reached nearly $300 million at the end of third quarter, up 5.3% since the beginning of the fiscal year, as new bookings continue to exceed shipments during that time.

Bear points

  • Bookings, meanwhile, totaled $59.1 million versus $60.1 million last year. The slight reduction mostly reflects factors impacting the timing of our orders. You might recall that we had very strong booking activity in the first half of the fiscal year.
  • Our consolidated financial statements prepared in accordance with IFRS show in the context of the transactions a loss from continuing operations of $47.8 million for the quarter and $50.6 million after nine months.
  • I draw your attention to the restructuring expenses of 74.5 million for the quarter and 81.3 million year-to-date representing adjustments which related primarily to the accelerated accretion of the asbestos-related provision to account for the expected settlement and transaction-related costs.
Read full transcript analysis ›